Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

212 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Febrile ulceronecrotic Mucha-Habermann disease.
López-Estebaranz JL, Vanaclocha F, Gil R, García B, Iglesias L. López-Estebaranz JL, et al. J Am Acad Dermatol. 1993 Nov;29(5 Pt 2):903-6. doi: 10.1016/0190-9622(93)70267-w. J Am Acad Dermatol. 1993. PMID: 8408838 Review.
Cutaneous plasmacytosis: report of a case in a white man.
López-Estebaranz JL, Rodriguez-Peralto JL, Ortiz Romero PL, Vanaclocha F, Iglesias Díez L. López-Estebaranz JL, et al. J Am Acad Dermatol. 1994 Nov;31(5 Pt 2):897-900. doi: 10.1016/s0190-9622(94)70255-1. J Am Acad Dermatol. 1994. PMID: 7962744
Possible paradoxical occurrence of inflammatory arthritis in patients with psoriasis treated with biologics: findings in the Biobadaderm cohort.
Ruiz-Genao D, Perez-Zafrilla B, Lopez-Estebaranz JL, Belinchón-Romero I, Carrascosa JM, Ferrán M, Vanaclocha F, Herrera-Ceballos E, García-Doval I; Biobadaderm Study Group. Ruiz-Genao D, et al. Br J Dermatol. 2017 Mar;176(3):797-799. doi: 10.1111/bjd.14690. Epub 2016 Oct 17. Br J Dermatol. 2017. PMID: 27120993 No abstract available.
Comparison of phenotype, comorbidities, therapy and adverse events between psoriatic patients with and without psoriatic arthritis. Biobadaderm registry.
Pérez-Plaza A, Carretero G, Ferrandiz C, Vanaclocha F, Gómez-García FJ, Herrera-Ceballos E, De la Cueva-Dobao P, Belinchón I, Sánchez-Carazo JL, Alsina M, López-Estebaranz JL, Ferrán M, Torrado R, Carrascosa JM, Llamas-Velasco M, Rivera R, Jiménez-Puya R, García-Doval I, Descalzo MA; Biobadaderm Study Group. Pérez-Plaza A, et al. J Eur Acad Dermatol Venereol. 2017 Jun;31(6):1021-1028. doi: 10.1111/jdv.14188. Epub 2017 Apr 12. J Eur Acad Dermatol Venereol. 2017. PMID: 28252811
Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registry.
Medina C, Carretero G, Ferrandiz C, Dauden E, Vanaclocha F, Gómez-García FJ, Herrera-Ceballos E, De la Cueva-Dobao P, Belinchón I, Sánchez-Carazo JL, Alsina M, López-Estebaranz JL, Ferrán M, Carrascosa JM, Torrado R, Argila D, Rivera R, Jiménez-Puya R, García-Doval I; BIOBADADERM Study Group. Medina C, et al. J Eur Acad Dermatol Venereol. 2015 May;29(5):858-64. doi: 10.1111/jdv.12688. Epub 2014 Sep 3. J Eur Acad Dermatol Venereol. 2015. PMID: 25185962
Association of the PDE3A-SLCO1C1 locus with the response to anti-TNF agents in psoriasis.
Julià A, Ferrándiz C, Dauden E, Fonseca E, Fernández-López E, Sanchez-Carazo JL, Vanaclocha F, Puig L, Moreno-Ramírez D, Lopez-Estebaranz JL, Herrera E, de la Cueva P, Ávila G, Alonso A, Tortosa R, López-Lasanta M, Marsal S. Julià A, et al. Pharmacogenomics J. 2015 Aug;15(4):322-5. doi: 10.1038/tpj.2014.71. Epub 2014 Nov 18. Pharmacogenomics J. 2015. PMID: 25403996
Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The percentage of patients with severe psoriasis on biologics increases over time.
Carrascosa JM, Rivera N, Garcia-Doval I, Carretero G, Vanaclocha F, Daudén E, Gómez-García FJ, De-la-Cueva-Dobao P, Herrera-Ceballos E, Belinchón I, Alsina M, Sánchez-Carazo JL, Ferrán M, Lopez-Estebaranz JL, Pérez-Zafrilla B, Llamas M, Rivera R, Ferrándiz C; BIOBADADERM Study Group. Carrascosa JM, et al. Actas Dermosifiliogr. 2015 Oct;106(8):638-43. doi: 10.1016/j.ad.2015.04.013. Epub 2015 Jun 30. Actas Dermosifiliogr. 2015. PMID: 26141003 Free article. English, Spanish.
Management of Biologic Therapy in Moderate to Severe Psoriasis in Surgical Patients: Data From the Spanish Biobadaderm Registry.
Galiano Mejías S, Carretero G, Ferrandiz C, Vanaclocha F, Daudén E, Gómez-García FJ, Herrera-Ceballos E, Belinchón-Romero I, Sánchez-Carazo JL, López-Estebaranz JL, Alsina M, Ferrán M, Torrado R, Carrascosa JM, Rivera R, Llamas-Velasco M, Jiménez-Puya R, Mendiola MV, Ruiz-Genao D, Descalzo MA, de la Cueva Dobao P; del grupo Biobadaderm. Galiano Mejías S, et al. Actas Dermosifiliogr. 2017 Jan-Feb;108(1):52-58. doi: 10.1016/j.ad.2016.08.003. Epub 2016 Sep 20. Actas Dermosifiliogr. 2017. PMID: 27658689 Free article. English, Spanish.
Guidelines on the Use of Methotrexate in Psoriasis.
Carretero G, Puig L, Dehesa L, Carrascosa JM, Ribera M, Sánchez-Regaña M, Daudén E, Vidal D, Alsina M, Muñoz-Santos C, López-Estebaranz JL, Notario J, Ferrandiz C, Vanaclocha F, García-Bustinduy M, Taberner R, Belinchón I, Sánchez-Carazo J, Moreno JC; Grupo de Psoriasis de la AEDV. Carretero G, et al. Actas Dermosifiliogr. 2010 Sep;101(7):600-613. doi: 10.1016/j.ad.2010.04.002. Epub 2010 Jul 31. Actas Dermosifiliogr. 2010. PMID: 28709542 English, Spanish.
212 results